According to Nova One Advisor, the global exosome research market size is calculated at USD 225.72 million in 2025 and is ...
QIAGEN N.V. today announced the launch of the EZ2 DNA Investigator Sep&Prep Kit, a fully automated solution for processing sexual assault samples, at the upcoming International Symposium on Human ...
QIAGEN today announced the 4,000th placement of its QIAcube Connect instrument, a significant milestone in driving automation adoption for sample processing across life science and diagnostic labs.
State Key Laboratory for Quality and Safety of Agro-Products, Key Laboratory of Biotechnology in Plant Protection of MARA, Zhejiang Key Laboratory of Green Plant Protection, Institute of Plant ...
Clonal hematopoiesis of indeterminate potential (CHIP) is a known risk factor for coronary artery disease, though its precise role in disease progression continues to emerge. This study leverages ...
The Netherlands Authority for the Financial Markets (AFM) has informed QIAGEN N.V. about a notification from Bank of America Corporation regarding voting rights and capital interest. The notification, ...
Accelerating protein production with high reproducibility is a key challenge in drug discovery and development. In this webinar, Karthik Rajasekar from Evotec department of Protein Sciences will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback